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Abstract
While infectious agents have typical host preferences, the noninvasive enteric bacterium
Vibrio cholerae is remarkable for its ability to survive in many environments, yet cause diar-
rheal disease (cholera) only in humans. One key V. cholerae virulence factor is its neuramin-
idase (VcN), which releases host intestinal epithelial sialic acids as a nutrition source and
simultaneously remodels intestinal polysialylated gangliosides into monosialoganglioside
GM1. GM1 is the optimal binding target for the B subunit of a second virulence factor, the
AB5 cholera toxin (Ctx). This coordinated process delivers the CtxA subunit into host epithe-
lia, triggering fluid loss via cAMP-mediated activation of anion secretion and inhibition of
electroneutral NaCl absorption. We hypothesized that human-specific and human-universal
evolutionary loss of the sialic acid N-glycolylneuraminic acid (Neu5Gc) and the consequent
excess of N-acetylneuraminic acid (Neu5Ac) contributes to specificity at one or more steps
in pathogenesis. Indeed, VcN was less efficient in releasing Neu5Gc than Neu5Ac. We
show enhanced binding of Ctx to sections of small intestine and isolated polysialoganglio-
sides from human-like Neu5Gc-deficient Cmah-/- mice compared to wild-type, suggesting
that Neu5Gc impeded generation of the GM1 target. Human epithelial cells artificially
expressing Neu5Gc were also less susceptible to Ctx binding and CtxA intoxication follow-
ing VcN treatment. Finally, we found increased fluid secretion into loops of Cmah-/- mouse
small intestine injected with Ctx, indicating an additional direct effect on ion transport. Thus,
V. cholerae evolved into a human-specific pathogen partly by adapting to the human evolu-
tionary loss of Neu5Gc, optimizing multiple steps in cholera pathogenesis.
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Author summary
Ingestion of food or water contaminated with the bacterium Vibrio cholerae can cause
fatal diarrheal disease (cholera) in humans, but not in other mammals exposed to the bac-
terium. This unusual pathogen uses a specialized enzyme V. cholerae neuraminidase
(VcN) to cleave sugars called sialic acids and thereby remodel host intestinal glycans, gen-
erating high levels of ganglioside GM1, the optimal ligand for the second secreted mole-
cule (cholera toxin, Ctx) that causes diarrhea. Humans lost the ability to produce a kind of
sialic acid called Neu5Gc during our evolution and the glycans of our small intestine are
different from most other mammals. We hypothesized that V. cholerae evolved into a
human-specific pathogen by adapting its virulence factor to optimally target human intes-
tinal glycans. We found that VcN remodeling of gangliosides into the Ctx ligand was slo-
wed by the presence of Neu5Gc. In keeping with this finding, incorporation of Neu5Gc
into human cells impedes facilitation of Ctx intoxication by VcN. Finally, human-like
Neu5Gc–deficient Cmah-/- mouse intestine was more susceptible to Ctx-induced intoxica-
tion, implicating a second, as yet undefined, mechanism dependent on the Neu5Gc loss in
humans. Thus, the unique glycan composition of human cells and human-like Neu5Gc-
deficient mice influences many steps of cholera pathogenesis. This could help explain, at
least in part, Robert Koch’s failure to find any nonhuman animal model susceptible to
diarrhea caused by V. cholerae.
Introduction
Cholera is a life-threatening, human-specific disease caused by the noninvasive enteric bacte-
rium Vibrio cholerae that affects millions of people worldwide [1]. Humans are infected after
ingestion of food or water contaminated with the pathogen. Bacteria that survive passage
through the acidic milieu of the stomach can colonize and multiply on the surface of the small
intestinal epithelium [2] and induce severe watery diarrhea. This main symptom of the disease
leads to loss of electrolytes and blood volume depletion, and can be fatal if the individual is not
rehydrated rapidly [2]. Cholera diarrhea is triggered after the B subunits of cholera toxin (Ctx)
bind to the monosialoganglioside, GM1 [3–5], expressed on the outer leaflet of the apical
membrane of intestinal epithelial cells, which facilitates toxin endocytosis and retrograde pha-
gosomal transport to the endoplasmic reticulum (ER) [6, 7]. In the ER, the enzymatically active
A subunit of Ctx (CtxA) is released from the B subunits and translocated into the cytoplasm,
where it activates adenylate cyclase, leading to increased levels of cyclic adenosine monophos-
phate (cAMP). The rise in cAMP causes intense secretion of chloride ions through the cystic
fibrosis transmembrane conductance regulator (CFTR) as well as inhibition of electroneutral
sodium chloride absorption [8]. These events are followed by passive water flow in response to
osmotic gradients, resulting in profuse diarrhea [9]. CtxA further induces epithelial cell barrier
disruption by inhibiting exocyst-mediated trafficking of host proteins that make up the inter-
cellular junctions of epithelial cells, a mechanism that may act in parallel with Cl− secretion to
drive the pathophysiology of cholera [10].
The pathogenesis of cholera-induced diarrhea is initiated when Ctx binds to GM1. How-
ever, this mono-sialoganglioside is naturally expressed only at low levels in the small intestine
compared to di- and tri-sialogangliosides such as GD1a, GD1b, GT1b, etc. [11]. Pioneering
studies on the tissue ligand for Ctx demonstrated that V. cholerae uses its uniquely evolved
neuraminidase (VcN) to hydrolyze α2-3- and α2-8-linked sialic acids from complex
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gangliosides, thereby generating high concentrations of GM1 and favoring the binding and
internalization of Ctx by mammalian cells [4, 12]. Thus, VcN-mediated cleavage of sialic acids
from multisialylated gangliosides (selectively sparing the one internal α2-3-linked sialic acid
that defines GM1) acts synergistically with Ctx in the induction of diarrhea.
Sialylated glycans (such as on glycoproteins and glycosphingolipids) from human cells ter-
minate with only the N-acetylneuraminic acid (Neu5Ac) isoform of sialic acid, a pattern that
differs from the majority of other mammals, whose glycans can also terminate with N-glycolyl-
neuraminic acid (Neu5Gc, which differs from Neu5Ac by one additional oxygen atom) [13].
Humans do not naturally express glycoconjugates containing Neu5Gc because they lack the
enzyme CMP-N-acetylneuraminic acid hydroxylase (CMAH) due to an Alu-mediated exon
deletion in the CMAH gene [14]. Thus, while gangliosides from other adult mammals such as
calf, pigs and rabbits can terminate in α2-3- and α2-8-linked Neu5Gc or Neu5Ac [15, 16], only
α2-3- and α2-8-linked Neu5Ac are found in human gangliosides [17].
Cholera is a human-specific disease. In fact, Robert Koch, one of the founders of modern
microbiology, famously wrote in 1884: “. . .although these experiments were constantly repeated
with material from fresh cholera cases, our mice remained healthy. We then made experiments
on monkeys, cats, poultry, dogs and various other animals [. . .] but we were never able to arrive
at anything in animals similar to the cholera process” [18]. Experimental high dose (~1 x 109
organisms) oral infection of cimetidine-treated 3-day-old infant rabbits with V. cholerae can
lead to lethal watery diarrhea [19]. However, to the best of our knowledge no reports of cholera
diarrhea in other adult mammals have been available, nor any theories to explain the human
specificity for this disease, which remains a long-standing mystery––a rare failure of Koch to
fulfill his own “postulates” for defining an infectious disease agent.
Previous studies from our group have shown that polymers of α2-8-linked Neu5Gc are
much less susceptible to cleavage by mammalian and bacterial neuraminidases compared to
polymers containing α2-8-linked Neu5Ac [20]. These findings led us to hypothesize that the
difference in the sialic acid composition between the glycans of humans and other mammals
influences the ability of VcN to generate epitopes for Ctx binding. This, together with previous
studies from our group showing that sialic acid type can modulate host-pathogen interactions
and human-specific susceptibility to other infectious diseases such as typhoid fever and malig-
nant malaria [21, 22], motivated us to investigate if the loss of Neu5Gc plays a role in human
susceptibility to cholera. In this paper, we explore a variety of possible mechanisms and their
potential link to the human-specific occurrence of cholera.
Results
Absence of Neu5Gc favors V. cholerae neuraminidase activity on complex
gangliosides and enhancement of Ctx binding
V. cholerae neuraminidase (VcN) can catalyze the cleavage of α2-3- and α2-8-linked sialic
acids from complex gangliosides with multiple sialic acids but it specifically does not cleave the
single sialic acid α2-3-linked to an internal galactose (Gal) residue present in the GM1 ganglio-
side [4, 12]. VcN action on polysialogangliosides is thus critical to generate high concentra-
tions of GM1 and favor the binding and internalization of Ctx by intestinal epithelial cells [4,
12]. Unrelated prior studies from our group have shown that glycans containing α2-8-linked
Neu5Gc are relatively resistant to hydrolysis by other bacterial neuraminidases compared to
glycans containing α2-8-linked Neu5Ac [20]. To study possible substrate preferences of VcN
for α2-8-linked sialic acids, glycan structures containing terminal α2-8-linked Neu5Ac or
Neu5Gc with underlying α2-3-linked Neu5Ac were exposed to increasing amounts of VcN
and the resulting glycans were probed with Hsa, a bacterial adhesin that specifically recognizes
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any exposed α2-3-linked terminal mono-sialic acid [23]. As seen in Fig 1A, de-sialylation of
Neu5Ac- or Neu5Gc-terminated sialoglycans with identical underlying glycan structures
depended on VcN concentration. When the outermost α2-8-linked sialic acid moiety was
removed by VcN, the underlying mono-sialic acid α2-3-linked to lactose became exposed and
susceptible to Hsa binding. The Neu5Ac-terminated sialoglycan was more readily cleaved by
VcN treatment than its Neu5Gc-terminated counterpart. Thus, VcN prefers Neu5Ac, and gly-
cans containing α2-8-linked Neu5Gc are less susceptible to VcN-mediated hydrolysis (Fig
1A). Interestingly, when higher concentrations of VcN were used, it could further cleave the
exposed terminal α2-3-linked Neu5Ac, resulting in a decrease of binding by Hsa, which specif-
ically recognizes terminal α2-3-linked mono-sialic acids (S1 Fig).
Since Neu5Gc compromises VcN activity, we next tested if VcN treatment would influence
the binding of Ctx to gangliosides isolated from WT and Cmah-/- mice. ELISA assays revealed
that treatment of small intestinal monosialogangliosides with increasing concentrations of
VcN did not influence the binding of Ctx in samples from either mouse (Fig 1B). This was
expected because VcN should not target monosialogangliosides to generate GM1 [24]. How-
ever, VcN treatment of di/tri/tetrasialo-gangliosides increased binding of Ctx to gangliosides
from Cmah-/- small intestine compared to gangliosides from WT mice (Fig 1C), suggesting
that higher levels of GM1 were generated by VcN activity on complex gangliosides in the
absence of Neu5Gc.
Even mammals that express CMAH in other tissues lack glycans containing Neu5Gc in
their brain, a tissue enriched in gangliosides. Correspondingly, although VcN treatment of di/
tri/tetrasialo-gangliosides isolated from the brain increased Ctx binding, the effect was compa-
rable between WT and Cmah-/- brain gangliosides (Fig 1D). Moreover, compared to WT con-
trols, Ctx binding to brain gangliosides after VcN treatment was significantly lower in samples
from NestinCre+-Cmahtg mice that were genetically modified to overexpress Neu5Gc in the
brain [25] (Fig 1E).
To extend the findings from the ELISA assay, we compared the binding of Ctx to small
intestinal tissue sections from WT and Cmah-/- mice by microscopy. Although there was no
significant difference in Ctx binding between WT and Cmah-/- tissues at baseline (Fig 2A, top
panels), treatment of frozen sections with VcN enhanced binding of Ctx to Cmah-/- (Fig 2A,
right panels) but not WT tissues (Fig 2A, left panels), as shown by the quantification of the
Ctx-positive (red) area (Fig 2B). Together with our previous biochemical observation that
absence of Neu5Gc facilitates VcN activity, these results suggest that higher levels of GM1
were generated in the tissue of Cmah-/- mice, thereby promoting Ctx binding to small intesti-
nal gangliosides of Cmah-/- mice.
VcN activity and Ctx-induced cAMP elevation are suppressed in human
T84 cells expressing Neu5Gc
To confirm that absence of Neu5Gc plays a role in the pathophysiologic changes induced by
VcN plus Ctx when CMAH is missing, we supplied exogenous Neu5Gc to human colonic cells
in culture, which would be metabolically incorporated into cell surface glycoconjugates. We
then analyzed VcN activity, Ctx binding and basal and stimulated cAMP levels in the cells that
had metabolically incorporated Neu5Gc. As seen in Fig 3, T84 cells fed with free Neu5Gc (5
mM) successfully incorporate it into cell surface glycans (Fig 3B, black arrow). This result cor-
roborates prior observations that human cells can incorporate Neu5Gc into nearly all major
glycans, including gangliosides [17]. Importantly, cells fed with Neu5Ac, used as a control for
sialic acid feeding, did not express detectable levels of Neu5Gc (Fig 3A). Using a whole cell
ELISA assay [26], we observed that simply incorporating Neu5Gc in the cell surface did not by
Human loss of Neu5Gc in the pathogenesis of cholera
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Fig 1. The presence of Neu5Gc compromises VcN activity and generation of epitopes for Ctx binding, compared to Neu5Ac. (a) Glass slides were
printed with the indicated synthetic structures and incubated with increasing amounts of VcN. The resulting slides were probed with the bacterial Hsa-BR
adhesin to detect exposed α2-3-linked mono sialic acid. Monosialogangliosides (b) and di-tritetrasialogangliosides (c) isolated from mice small intestine
mucosa or from the brain (d and e) were treated with increasing amounts of VcN and incubated with 10ug/mL of biotin-conjugated B subunit of Ctx.
Samples of gangliosides isolated from the brain of mice genetically engineered to express Neu5Gc in the brain [25] are referred as NestinCre+-Cmahtg in
figure (e). For all samples, Ctx binding was measured after incubation of the wells with HRP-Streptavidin and OPD substrate. The graphs are representative
of three independent technical replicates using the batch of gangliosides isolated as described in the methods (p<0.05).
https://doi.org/10.1371/journal.ppat.1007133.g001
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itself affect Ctx binding to T84 cells (Fig 3C). However, when cells fed with Neu5Ac were also
exposed to VcN, binding of Ctx was significantly increased, whereas VcN had no effect on Ctx
binding to cells fed with Neu5Gc (Fig 3C). Further, VcN significantly increased the ability of
Ctx to elevate cAMP in cells fed with Neu5Ac- but not in Neu5Gc-fed cells (Fig 3D). Thus,
lack of Neu5Gc makes glycans of human cells more susceptible to VcN activity in generating
Ctx-binding and subsequent cell intoxication.
Human-like Cmah-/- mouse small intestine is more susceptible to Ctx-
induced fluid secretion
Since lack of Neu5Gc increased Ctx binding to the small intestinal gangliosides of Cmah-/-
mice, and exogenous incorporation of Neu5Gc blocked the ability of VcN to increase Ctx tox-
icity in human cells, we next studied pathogenic effects of both virulence factors in WT vs.
Cmah-/- mice. We hypothesized that WT mice that express Neu5Gc would be less susceptible
to VcN-generation of GM1 from α2-8-sialylated gangliosides and thus develop fewer epitopes
for Ctx binding. Conversely, Cmah-/- mice should be more susceptible to Ctx-mediated fluid
secretion because more GM1 would be readily generated from the α2-8-sialylated gangliosides
due to the lack of Neu5Gc. Because adult mice have many compensatory mechanisms to pre-
vent fluid loss, and therefore do not typically develop frank diarrhea following oral infection
with V. cholerae (or many other non-invasive intestinal pathogens) [27–29], researchers have
used ligated intestinal loops to study Ctx-induced pathogenesis [30, 31]. Using the same well-
established model, we injected Ctx into intestinal loops created in WT and Cmah-/- mice. After
Fig 2. Ctx binding to small intestine frozen sections exposed to VcN is improved in the absence of Neu5Gc. (a) Fluorescence microscopy from frozen sections of
small intestine from WT and Cmah-/- mice incubated with biotin-conjugated B subunit of Ctx alone (top panels) or treated with 10 mU (middle panels) or 50 mU
(bottom panels) of VcN. (b) Ctx binding was determined by incubation with Cy3-conjugated streptavidin and the Cy3 positive were quantified as Ctx binding area
using imageJ. (p<0.05).
https://doi.org/10.1371/journal.ppat.1007133.g002
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4 h, Ctx induced fluid accumulation in both mice, but fluid levels were significantly higher in
the intestinal loops of Cmah-/- mice (Fig 4A and 4B). Corroborating this finding, incubation of
jejunal segments with Ctx in Ussing chambers increased ion transport (most likely reflective of
electrogenic chloride secretion) in Cmah-/- specimens compared to that in WT tissue (Fig 4C).
Basal ion transport was also upregulated in tissues from Cmah-/- mice compared to WT, but
there was no significant difference in ion secretion induced by forskolin between WT and
Cmah-/- tissues (Fig 4C). This latter finding implies that the enhanced ion transport response
of Cmah-/- tissues to Ctx is not simply due to differences in responsiveness of the ion transport
machinery to intracellular cAMP. VcN addition to the intestinal loops or to the apical reservoir
in the Ussing chamber did not affect Ctx-induced fluid (Fig 4B) or ion secretion across either
WT or Cmah-/- tissues (Fig 4C). However, unlike the effect of VcN treatment in the tissue sec-
tions, the apically-applied enzyme would face competitive inhibition by the heavy overlying
Fig 3. Human cells expressing Neu5Gc are resistant to VcN activity in generating Ctx binding and cell intoxication. (a-b) DMB-HPLC analysis for sialic acid
incorporation in the cell surface glycans of T84 cells fed with 5mM of Neu5Gc (right histogram) or 5mM of Neu5Ac (left histogram) as a control. Arrow indicates
the Neu5Gc-corresponding peak in Neu5Gc fed cells that is absent in Neu5Ac fed cells. NT = Not treated. (c) Whole cell ELISA (6 wells for each condition) for Ctx
binding to T84 cells with or without VcN treatment. (d) Quantification of cAMP production induced by CtxAB5 with or without VcN treatment calculated for
three different wells (biological triplicates) for each condition. Graphs represent one of three independent experiments. Black bars—Neu5Gc fed cells. Gray bars
Neu5Ac expressing cells. (p<0.05 and p<0.005).
https://doi.org/10.1371/journal.ppat.1007133.g003
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layer of sialylated intestinal mucins and therefore could not reach the ganglioside structures.
In natural human infection the bacterium may deploy other virulence mechanisms to reach
the epithelial surface. Despite the lack of an efficient VcN-mediated desialylation process in
this model, a significant increase in the fluid secretion from Cmah-/- tissue nevertheless
occurred, indicating that these mice are more susceptible to the action of Ctx itself, by an as
yet unknown mechanism. In summary, our results show that the absence of glycans containing
Neu5Gc makes the intestinal tissue of Cmah-/- mice more susceptible to the pathogenic effects
of Ctx.
It is well known that changes in the mucin expression profile in murine small intestine can
alter tissue permeability [32, 33]. In addition, Ctx-mediated impairment of endosome recy-
cling disrupts tight junction integrity and thus the intestinal barrier [10], which might enhance
fluid loss. Because the mucins of WT and Cmah-/- mice small intestine differ in their sialic acid
composition, it was important to determine if the absence of Neu5Gc influenced intestinal per-
meability to account for increased Ctx-induced fluid secretion across Cmah-/- small intestine.
However, no differences in intestinal FITC-dextran permeability were seen between WT and
Cmah-/- mice (Fig 4D).
Fig 4. Increased susceptibility of Cmah-/- small intestine to Ctx-induced fluid secretion. (a) Representative pictures of Intestinal loops of WT and Cmah-/- treated
with 100uL of PBS containing 10μg/mL of Ctx during 4 h. (b) Quantification of fluid accumulation in intestinal loops treated with 100uL of PBS containing 10μg/mL of
Ctx plus and minus 10mU of VcN during 4 h, based on the loop weight/length ratio. (c) Ussing chamber measurement of ion secretion from small intestine fragments
(black bars for WT and gray bars for Cmah-/-) exposed to 10ug/mL of active CtxAB5 for 4 h (n = 4) or Forskolin exposure (p<0.05). (d) Measurement of FITC recovery
in the serum of mice treated with FITC-dextran by oral gavage.
https://doi.org/10.1371/journal.ppat.1007133.g004
Human loss of Neu5Gc in the pathogenesis of cholera
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Human-like absence of Neu5Gc in mice does not influence small intestinal
colonization by V. cholerae
To deliver Ctx and induce diarrhea, V. cholerae must colonize the host small intestine in a pro-
cess mediated by many different virulence factors [19, 34–37]. V. cholerae successfully colo-
nizes the human small intestine but is unable to naturally colonize the intestines of other adult
mammals studied to date [38]. In addition, Ctx-induced secretion of sialylated mucins plays
an important role in V. cholerae colonization of the intestinal tract [39, 40]. Since mucins from
Cmah-/- mice mimic mucins of human tissues by completely lacking Neu5Gc, we analyzed
whether the absence of Neu5Gc could influence colonization by V. cholerae. Although we
found different levels of bacteria along the small intestine and colon of the infected mice, the
bacterial CFU recovered from the small intestinal fractions were similar in both WT and
Cmah-/- mice (S2 Fig). These results suggest that the colonization of the small intestine of
Cmah-/- mice by V. cholerae is not significantly modulated by the absence of Neu5Gc. We next
wanted to investigate V. cholerae growth in minimum media containing either Neu5Ac or
Neu5Gc as sole carbon source and without competition from other bacteria. While V. cholerae
growth was modestly sensitive to sialic acid differences at high concentrations (such as 3 mM),
no differences in bacterial growth were observed at lower concentrations of the two monosac-
charides (S3 Fig).
Although similar levels of V. cholera were recovered from the gut tissues of both WT and
Cmah-/- mice, we asked if increased susceptibility of Cmah-/- small intestine to Ctx-induced
fluid secretion (Fig 4A, 4B and 4C) would make those animals develop diarrhea after ingesting
live V. cholerae. Neither WT nor Cmah-/- mice gavaged with 2 × 108 CFU of V. cholerae showed
any signs of diarrhea. Thus, although the lack of Neu5Gc increases susceptibility to Ctx toxic-
ity, the Cmah-/- background is not sufficient in itself to make mice susceptible to frank experi-
mental diarrhea induced by oral infection with V. cholera. These results corroborate previous
studies that have shown that adult mice do not develop diarrhea following oral infection with
V. cholerae, although the bacteria are able to replicate in the host gut (S2 Fig) [41].
Discussion
There are multiple potential mechanisms by which the human evolutionary loss of epithelial
Neu5Gc could contribute to the human-specific susceptibility to cholera. These include
improved survival in gastric fluid (not studied here); colonization or preferential growth with
Neu5Ac or Neu5Gc as carbon source (no effect seen here); decreased VcN degradation of
inhibitory mucin sialic acids (not studied here); VcN remodeling of higher gangliosides into
GM1 (a major impact seen here); improved delivery of the CtxA subunit into the cytosol (not
studied here); and cAMP production and chloride channel activation (both shown here to be
markedly enhanced). While some hypotheses were nullified, we discovered more than one
likely contributory mechanism that could underlie the human-specific susceptibility to
cholera.
We demonstrated that VcN shared its substrate preference with other previously studied
mammalian and bacterial sialidases [20], in being much less able to cleave α2-8-linked
Neu5Gc than α2-8-linked Neu5Ac, which also corroborates another recent report [42]. We
additionally showed that higher amounts of VcN are required to cleave an inner α2-3-linked
sialic acid after removal of the outer α2-8-linked sialic acid, indicating that VcN has a prefer-
ence for α2-8- over α2-3-linked sialic acids. Previous reports showed that VcN hydrolyses α2-
3-sialyl galactoside more efficiently than α2-6-sialyl galactoside [43, 44]. Taken together, we
theorize that V. cholerae neuraminidase evolved to target human gangliosides preferentially,
which are terminated only by Neu5Acα2-8-Neu5Acα2-3Gal1- and/or Neu5Acα2-
Human loss of Neu5Gc in the pathogenesis of cholera
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3Galβ1-linked sialic acids. Nonetheless, the presence of α2-8-linked Neu5Gc on gangliosides
compromised VcN hydrolysis, which fits our findings concerning the increased generation of
GM1 binding sites for Ctx in the small intestine of Cmah-/- mice. Our results also show that
VcN treatment affects the binding of Ctx to gangliosides isolated from the small intestine and
brain of Cmah-/- and NestinCre+-Cmahtg mice, demonstrating that gangliosides lacking
Neu5Gc are better targets for VcN to generate GM1 from a mixture of complex gangliosides.
It is worth mentioning that the differences in Ctx binding observed in our experiments should
solely correlate with the amount of GM1 generated after VcN action, since Ctx itself binds
equally to either Neu5Gc-GM1 and Neu5Ac-GM1 [16].
Human cells induced to express glycans containing Neu5Gc are less susceptible to VcN
activity, and therefore permit less generation of the optimal GM1 target for Ctx. The loss of
Neu5Gc in humans confers increased susceptibility to VcN, which in turn favors Ctx-induced
toxicity in intestinal cells. However, an additional mechanism evidently makes the small intes-
tine of human-like Cmah-/- mice more susceptible to Ctx-induced fluid secretion.
Early studies using germ-free mice demonstrated that the mouse gut microbiota is a natural
impediment to V. cholerae colonization [45]. Because of this, many studies have used oral
treatment with streptomycin as a colon dwelling model to study intestinal infection by this
bacterium [46, 47]. In fact, providing streptomycin in the drinking water did allow the coloni-
zation of the gastrointestinal tract of both WT and Cmah-/- mice by V. cholerae. Additional
studies have shown that the catabolism of sialic acid initiated by VcN is an important step for
intestinal colonization and the pathogenesis of cholera [48] and that V. cholerae can grow in
vitro when sialic acid is used as the sole carbon source [49]. Here, we show that V. cholerae col-
onizes the small intestine of WT and Cmah-/- mice similarly, corroborating previous data that
the bacteria can use both Neu5Ac and Neu5Gc as nutrient sources [49].
During natural infection, live bacteria depend critically on their toxin-coregulated pilus
(TCP) structure to colonize the human small intestine [34–36]. The action of TCP helps the
bacteria to get through the mucin barrier [50] and facilitates their direct contact with the epi-
thelial surface where VcN and Ctx act locally to induce diarrhea. We suspect that when puri-
fied VcN is injected into the lumen, it heavily engages the highly sialylated mucin layer
overlying the epithelial surface and therefore does not reach the relevant ganglioside structures
to generate GM1. This could explain why treatment with VcN did not potentiate the effect of
Ctx in tissue segments mounted in Ussing chambers. In keeping with this rationale, VcN treat-
ment did increase Ctx binding to frozen sections of the small intestine, wherein the mucus bar-
rier is bypassed by tissue sectioning.
A recent study elegantly showed that human T84 cells have little or no GM1 and that fuco-
sylated and sialylated glycoproteins are instead the main target for Ctx binding to those cells
[26]. Follow up studies further demonstrated that Ctx binds to fucosylated Lex-carrying glyco-
proteins but not to Lex-carrying glycolipids and that human and mouse intestinal cells can be
intoxicated by Ctx, even when glycosphingolipid synthesis in inhibited [51]. Although these
very interesting findings shed new light in the understanding of additional binding sites for
Ctx, which are likely to also be relevant in disease pathogenesis, the authors did not study the
impact of VcN in the Ctx binding to glycoproteins. We hypothesize that VcN would hydrolyze
α2-3- and α2-6-linked sialic acid from glycoproteins to prevent Ctx binding to such molecules.
VcN would also degrade di-tri sialylated gangliosides to generate GM1 and Ctx binding (See
Fig 5). Together with the above arguments, our data suggest that intestinal cells with Neu5Gc-
containing gangliosides are less susceptible to the toxicity of Ctx, and that this occurs at least
in part due to the differential action of VcN on Neu5Gc compared to Neu5Ac-containing gan-
glioside targets.
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Fig 5. Schematic representation of VcN-mediated remodeling of mucosal complex gangliosides to GM1 and possible VcN-independent mechanisms
that lead to increased susceptibility to Ctx intoxication in the absence of Neu5Gc. VcN cleaves α2–8 and α2-3-linked sialic acids from di-, tri-, and tetra-
sialylated gangliosides to generate the monosialylated ganglioside, GM1. Importantly, VcN is not able to cleave the α2-3-linked sialic acid in the GM1 and
thus it the optimal target for Ctx is retained. Di-, tri-, tetra-sialylated gangliosides from WT mice (containing α2-8-linked Neu5Gc) are resistant to VcN
cleavage and thus much less GM1 is generated (a—left panels). In contrast, VcN more efficiently cleaves di-, tri-, and tetra-sialylated gangliosides from
Cmah-/- mice, resulting in increased binding of Ctx (a—right panels). In keeping with this rationale, the remodeling of human gangliosides to GM1 that is
catalyzed by VcN (b—right panels) occurs at much higher levels than in non-human mammalian cells (b—left panels). We show here that there is also an
unknown VcN-independent mechanism by which the small intestine of Cmah-/- mice is more susceptible to Ctx intoxication. We speculate that the
increased levels of ion secretion across the small intestine of Cmah-/- mice produced by Ctx also rely on changes in the hydrophobic/hydrophilic properties
of the cell surface glycocalyx (c). Epithelial cells surfaces may contain up to 108 residues of sialic acids. Thus, the abundance of hydroxyl groups in Neu5Gc-
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Although the data generated using the mouse model neither supported nor ruled out the
hypothesis that VcN action enhanced the generation of GM1 target in isolated gangliosides,
we found the small intestine of Cmah-/- mice secreted much higher levels of fluid in response
to Ctx, suggesting additional mechanisms by which loss of Neu5Gc increases host susceptibil-
ity to Ctx. Fluid secretion results from both intense Cl- secretion through CFTR reflected as
changes in short circuit current [52] as well as inhibition of NaCl absorption, which cannot be
assessed in Ussing chambers. Glycosylation of CFTR is crucial for its function, affecting its cell
surface expression, conformation stability and lysosomal degradation [53]. CFTR in Cmah-/-
mice will only contain glycans with Neu5Ac, unlike CFTR glycans in WT mice (and adult
mammals other than humans) that would express both Neu5Gc and Neu5Ac. We speculate
that the differences in CFTR glycosylation could influence the increased electrogenic ion trans-
port across Cmah-/- small intestine as observed in Ussing chambers, and also the intense fluid
secretion in the Cmah-/- intestinal loops.
Enterotoxigenic E. coli (ETEC) produce a heat labile enterotoxin (LT), which is ca. 80%
identical to Ctx, and acts by a similar mechanism also binding to GM1 [54]. Yet ETEC infects
both humans and animals and does not produce a neuraminidase. With ETEC, the difference
between strains that infect animals and strains that infect humans is may rely on both entero-
toxin and intestinal colonization factors such as CFAI or K88 [54] that confer species specific-
ity in binding of the whole bacterium. At first glance the situation with ETEC would seem to
argue against our conclusions that the VcN specificity and differences in intestinal sialic acids
accounts for V. cholerae being a human-specific pathogen. However, there is a major differ-
ence between the pathogens that needs to be considered. Whereas ETEC LT can only bind to
the very small amount of GM1 naturally present in the gut mucosal epithelia, VcN provides
extensive trimming of the complex gangliosides, maximizing the production of a much larger
amount of GM1 target that, as a striking coincidence, is completely resistant to further VcN
cleavage (See Fig 5). Indeed, this difference can help explain the much greater severity of the
diarrhea in terms of volume loss in cholera than in ETEC infections. We do not rule out the
possibility that the human specificity of cholera may also include other components such as
species-specific intestinal colonization factors.
Taken together, our results show that the evolutionary loss of epithelial Neu5Gc is a poten-
tial mechanism that contributes, at least in part, to the human-specific susceptibility to cholera,
and can explain what appears to be one of the rare instances in which Robert Koch was unable
to fulfill his famous postulates [18] for a human infectious disease: isolate the organism from
the natural host, grow it in culture and introduce it back into an animal model host to repro-
duce the disease.
Materials and methods
Reagents
T84 cells (American Type Culture Collection—CCL-248), a line derived from a lung metasta-
sis of a human colorectal carcinoma, were used as previously described [55]. The active (AB5)
form of Ctx, 4 kDa labeled FITC-dextran and 1,2-diamino-4,5-methylenedioxybenzene
(DMB) were obtained from Sigma-Aldrich (St. Louis, MO, USA). V. cholerae neuraminidase
was purchased from Roche (Clovis, CA, USA). The cAMP ELISA kit was from R&D Systems
positive cells increases the hydrophilicity of their glycocalyx. On the other hand, the glycocalyx of human cells should be less hydrophilic since it only
contains glycans with Neu5Ac. Although not studied here, it is also possible that CFTR glycosylation differs in the absence of Neu5Gc, perhaps modulating
its trafficking to the cell suface in response to Ctx (c).
https://doi.org/10.1371/journal.ppat.1007133.g005
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(Minneapolis, MN, USA). V. cholerae strain N16961 was acquired from ATCC (Manassas, VA,
USA).
Determination of V. cholerae neuraminidase substrate preference by a pair
of Neu5Ac- vs. Neu5Gc-terminated glycans
The pairs of glycans [56] were printed on glass slides. Resulting slides were blocked with etha-
nolamine, washed, dried, and then fitted into a hybridization cassette [21, 23]. The slides were
then blocked with ovalbumin (1% w/v) in PBS (pH 7.4) for 1 h at RT, with gentle shaking. Sub-
sequently, various amounts of VcN were applied to the glass slides. After incubating for 2 h,
the slides were extensively washed to remove the neuraminidase. A GST-tagged bacterial adhe-
sin probe, Hsa, which specifically recognizes mono sialic acid α2-3-linked to underlying glycan
structures [23] was applied and incubated for 2 h at RT with gentle shaking, followed by anti-
GST antibodies (1:2000 dilution in DPBS) and Alexa Fluor 555-conjugated anti-rabbit IgG
(1:10.000 in DPBS) incubation. Resulting slides were washed and dried. Finally, the slides were
scanned with a Genepix 4000B scanner (Molecular Devices Corp., Union City, CA). Data were
analyzed with the Genepix Pro 7.0 analysis software.
Mice
Cmah−/− mice, generated as previously described [57], were bred onto a congenic C57BL/6
background and maintained in the University of California, San Diego vivarium according to
Institutional Animal Care and Use Committee (IACUC) guidelines. Cmah−/− and WT mice
were raised in the same vivarium room, in the same cage rack and fed with the same chow and
water source to avoid variations in the gut microbiome. Both male and female mice from 8–14
weeks of age were used for all experiments.
Ethics statement
All studies were approved by the UC San Diego Institutional Animal Care and Use Committee
(IACUC) under the protocol number S01227. All studies complied with federal regulations
regarding the care and use of laboratory animals: Public law 99–158, the Health Research
Extension Act, and Public Law 99–108, the Animal Welfare Act which is regulated by USDA,
APHIS, CFR, Title 9. Parts 1, 2, and 3.
Ganglioside purification
Mice were euthanized in the humane CO2 chamber according to our animal protocol approval
and the small intestine of WT and Cmah-/- mice and brain tissues from WT, Cmah-/- and Nes-
tinCre+-Cmahtg [25] were harvested. Brains were bisected in the sagittal plane and the small
intestine mucosa was exposed using a blunted pair of scissors. The mucosa was then harvested
using a cell scraper. Approximately 4 g of small intestinal mucosa and 0.5 g of brain tissue
were homogenized in 4 volumes of ice-cold water using a polytron homogenizer and a total
lipid extraction from both tissues was performed as previously described [58]. Briefly, ganglio-
sides from both tissue preparations were purified from neutral glycolipids by running the total
lipid phase through a DEAE-Sephadex (Bio-rad) column as previously described [59]. Next,
the fractions containing monosialogangliosides were eluted from the column using 0.01 M
ammonium acetate and the di/tri/tetrasialo-gangliosides were eluted with 0.5M ammonium
acetate. Gangliosides in each fraction were quantified using DMB derivatization and HPLC
analysis as previously described [17] and the concentration of sialic acid was used to normalize
for the ganglioside concentration.
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ELISA for Ctx binding to purified gangliosides
96 well plates (Cat: 9018 –Corning, USA) were coated with 100 μL of 0.2 nM of gangliosides
purified from mouse brain and small intestine and left to dry overnight at RT. On the next
day, the wells were washed 3 times with PBS and incubated with increasing amounts of VcN
diluted in PBS for 45 min. The wells were washed 3 times with PBS and blocked with PBS con-
taining 5% bovine serum albumin (BSA) for 2 h at RT. The blocking solution was aspirated
from the wells and 100 μL of 40 μg/mL biotin-conjugated Ctx B subunit were added for 45
min. The wells were washed 3 times with PBS and 100μL of 1:5000 dilution HRP-streptavidin
was added for 45 min. The wells were washed 3 times and 140 μL of O-phenylenediamine
dihydrochloride (OPD) solution was added for approximately 10 min until the reaction was
stopped with 40 μL of 4M H2SO4 solution and read at 490 nm.
Fluorescence microscopy for Ctx binding to the small intestine
Samples of jejunum from freshly harvested WT or Cmah-/- mouse small intestine, were flash
frozen in optimal cutting temperature (OCT) and dry ice/isopentane slurry. Frozen sections
were prepared at 5 μm and briefly air-dried, followed by blocking of endogenous biotin and
then overlaid with 10 μg/mL of biotin-conjugated B subunit of Ctx either alone, or together
with either 10 or 50 mU/mL of VcN, both diluted in PBS containing Ca2+ and Mg2+, for 45
min at RT. Following washes in PBS, the slides were incubated for 45 min with a 1:500 dilution
of Cy3-conjugated streptavidin and then the nuclei were counter stained with Hoecsht. Digital
images were captured using a Keyence BZ9000 using 10x and 40x magnification. Frozen sec-
tions from the small intestines of 4 WT and 4 Cmah-/- mice were used for the fluorescence
overlay assay using the following number of sections for each condition: Ctx (WT n = 5;
Cmah-/- n = 4); VcN 10 mU + Ctx (WT and Cmah-/- n = 5); VcN 50 mU + Ctx (WT and
Cmah-/- n = 4). The percentage area per picture showing binding with Ctx was calculated
using the formula (% of total fluorescent area—% Hoechst fluorescent area = % of Ctx positive
area) using ImageJ 1.50i software. The observer who captured the pictures was blinded for the
experimental groups.
Ligated intestinal loop
To study the effect of VcN and Ctx on fluid secretion, mouse small intestinal loops were stud-
ied as previously described [10, 30, 31]. Briefly, WT and Cmah-/- mice were anesthetized with a
single intraperitoneal injection of 100 μL of a ketamine (70 mg/kg) + xylazine (10 mg/kg) solu-
tion in PBS. A midline laparotomy was performed and one ligated intestinal loop ( 3 cm)
was formed in the jejunum of each animal using 5–0 USP 12 mm sutures. 100 μL of PBS con-
taining 10 μg/mL of the active form of Ctx (AB5 Ctx) plus or minus 10mU of VcN were
injected into the loop. The ligated loops were returned to the abdominal cavity, and the mice
were kept anesthetized for 4 h with the body temperature kept at 37˚C using heating pads. The
animals were then euthanized in a CO2 chamber and the intestinal loops were excised and
weighed to determine fluid accumulation, which was expressed as mg per cm of loop length.
Ussing chamber analysis
An electrophysiological analysis of electrogenic ion transport across mouse intestinal segments
was performed using an Ussing chamber system (Physiologic Instruments Inc., San Diego,
CA, USA) as previously described [60]. Segments of jejunum from WT or Cmah-/- mice were
mounted in Ussing chambers (window area: 0.1 cm2) and both apical and basolateral hemi-
chambers were filled with Ringer’s bicarbonate buffer containing (in mM): 140 NaCl, 25
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NaHCO3, 2.4 KH2PO4, 0.8 K2HPO4, 1.2 CaCl2, 0.8 MgCl2 (pH 7.4). 10 mM mannitol or 10
mM glucose were added to the apical and basolateral hemichamber buffers, respectively. The
solution was continuously bubbled with 5% CO2/95% O2 and maintained at 37˚C. Tissues
were voltage-clamped to zero potential difference by the application of short-circuit current
(Isc), and a baseline was established as previously described [60]. Ctx (10 μg/mL) and/or VcN
(10 mU/mL) were then added to the apical hemichambers and changes in Isc (ΔIsc), reflective
of electrogenic chloride secretion, were measured at 4 h after treatment. Tissues from both
mouse strains were also treated with forskolin (20 μM) and the ΔIsc was calculated at the time
of peak response.
Measurement of intestinal permeability in vivo
To compare intestinal permeability in WT and Cmah-/- mice, both strains were orally gavaged
with 44 mg of 4 kDa FITC-dextran per 100 g of body weight. The flux of FITC-dextran from
the intestine to the bloodstream was determined 4 h after gavage by spectrophotofluorometry
with 485 nm excitation and 528 nm emission wavelengths as previously described [61, 62].
HPLC analysis for Neu5Gc incorporation into cell surface glycans of T84
cells
T84 cells were maintained in 1:1 DMEM-F12 medium supplemented with 5% newborn calf
serum and 1% penicillin/streptomycin solution at 37˚C and 5% CO2. To study the ability of
these cells to incorporate Neu5Gc, 5 mM free Neu5Gc (INALCO) was added to the medium
for three days using the same culture conditions. The incorporation of sialic acid into cell sur-
face glycans was confirmed by DMB-HPLC analysis as previously described [17]. Briefly, the
cells were detached with PBS containing 0.5 mM EDTA and submitted to hypotonic lysis in
0.1X diluted in water with three cycles of freezing (-70˚C) and thawing (37˚C). The resulting
lysate was centrifuged at 25,000 RPM for 15 min and the pellets containing the cell membrane
fractions were subjected to acid hydrolysis with 0.1 M H2SO4 at 80˚C for 1 h to release sialic
acid bound to cell membranes. After hydrolysis, the samples were centrifuged at 25,000 RPM
for 15 min and the supernatant was filtered through an Amicon 10K column and derivatized
in DMB reagent for 150 min at 50˚C. The incorporation of Neu5Gc was analyzed by HPLC as
previously described [17].
In cell ELISA for Ctx binding to T84 cells
To investigate if Neu5Gc-containing glycans would influence Ctx binding, 25,000 T84 cells
per well were seeded in 96-well (Cat: 353072 –Falcon, USA) plates and exposed to 5 mM free
Neu5Ac or Neu5Gc for three days as described above. On the third day, the binding of Ctx to
T84 cells was performed as previously described [26] with some modifications. Cells were
washed 2 times in RT PBS and further incubated with 10mU of VcN in PBS pH 6 for 30 min at
RT. The wells in the same plate that were not treated with VcN were kept in PBS at pH 6 in
parallel. After VcN treatment, the wells were washed twice in cold PBS and incubated with
5 μg/mL of biotinylated Ctx B-subunit (CTB) in PBS (containing 1 mM CaCl2, 1 mM MgCl2,
0.2% (w/v) BSA, and 5 mM glucose) for 20 min on ice. Unbound biotin-CTB was removed by
washing 3 times in cold PBS and the cells were fixed with 4% paraformaldehyde for 10 min on
ice and 20 min at RT. After 3 washes with PBS, cells were blocked with 1% BSA/PBS for 45
min and incubated with HRP-streptavidin (Roche) at 1:10.000 dilution in PBS. HRP activity
was measured by adding ortho-phenylenediamine (OPD) substrate and reading at 490 nm in a
microplate reader (Molecular Devices). All values were corrected by light absorbance at 650
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nm and normalized to total cell protein content (bicinchoninic acid assay, Pierce BCA protein
assay kit, Pierce).
cAMP measurement
To study whether Neu5Gc influences the activity of VcN and Ctx on intracellular levels of
cAMP, 1 × 105 T84 cells per well were seeded in 12-well plates (Cat: 353043—Corning Inc,
USA) and treated for 3 days with 5 mM free Neu5Gc as described previously [63]. Cells fed
with 5mM Neu5Ac were used as controls. After 3 days, fresh medium with no sialic acid was
added. Cells were then treated with Ctx (10 μg/mL) in the presence or absence of VcN (10
mU/mL) for 6 h at 37˚C and 5% CO2. The cells were washed twice with ice-cold PBS and the
lysate was used to measure cAMP according to the manufacturer’s instructions. In parallel, the
percentage of cell surface Neu5Gc vs. Neu5Ac was measured by DMB-HPLC on the third day
after feeding as described elsewhere [64].
Oral infection with V. cholerae El Tor N16961
For intestinal tissue colonization, V. cholerae El Tor serovar O:1 strain N16961 was grown over-
night at 37˚C from a -80˚C frozen glycerol stock in Luria-Bertani broth (LB) medium. The next
day, the overnight culture was centrifuged at 4000 rpm for 5 min and the pellet resuspended in
300 mM sodium bicarbonate (NaHCO3) buffered solution, pH 9.0. As per the streptomycin-
treated model of cholera infection [47], mice were treated with 5 mg/mL of streptomycin
(Sigma) in their drinking water one day before infection. The concentration of streptomycin
was then lowered to 0.25 mg/ml for the duration of the experiment. Each animal received 1×108
CFU in 100 μL of the above NaHCO3 buffer via oral gavage. At each time point, animals were
humanely euthanized in CO2. The small intestine and colon were excised from the mice and
the small intestine was divided into duodenum, jejunum, and ileum. Intestinal sections were
opened lengthwise and stool was gently removed by washing in sterile PBS. Intestinal tissue was
then cut into small segments and homogenized. Cholera CFU were enumerated by serial dilu-
tion and plating on Thiosulfate-citrate-bile salts-sucrose agar (TCBS) media.
In vitro growth curve of V. cholerae in M9 minimal media containing
different sialic acids
For in vitro growth curves, V. cholerae El Tor serovar O:1 strain N16961 was grown overnight
as per oral infection. The overnight bacteria culture was diluted the next day at 1:20 into fresh
LB medium and grown to early log phase at 37˚C, corresponding to an optical density at 600
nm (OD600 nm) of 0.4. One mL of bacterial suspension was then spun down at 13,200 rpm for
5 min, washed and resuspended in M9 minimal media comprised of Na2HPO4 (6 g/L),
KH2PO4 (3 g/L), NaCl (0.5 g/L), NH4Cl (1 g/L), MgSO4 (2 mM), and CaCl2 (0.1 mM). Bacteria
(10 μL) were then added to 1 mL of M9 minimal media containing 0.2% (w/v) glucose, as well
as M9 minimal media with 0.2% glucose plus Neu5Ac or Neu5Gc (3 mM, 1.5 mM, 0.75 mM,
or 0.375 mM). Each inoculated media (200 μL) was added, in quadruplicate, to a Honeycomb
plate and covered with a lid. Bacteria were then grown at 37˚C for 24 h on a Bioscreen C
(Bioscreen Inc). Growth was monitored by OD600 nm readings at 30 minute intervals, and the
growth curve was analyzed using GraphPad Prism version 7.
Statistical analysis
Statistical analyses for two-group comparisons were performed using an unpaired Student’s t
test. Analyses for multiple group comparisons were done using one-way ANOVA and
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Bonferroni post-test. Both analyses were performed using GraphPad Prism version 7. The data
are represented as means ± standard deviation (SD) and P values of<0.05 were considered to
represent statistically significant differences.
Supporting information
S1 Fig. Hydrolysis of α2-3-linked sialic by high amounts of VcN. Glass slides printed with
the indicated synthetic structures were incubated with high amounts of VcN. The resulting
structures were probed with bacterial Has adhesin to evaluate the cleavage of α2-3-linked
mono sialic acid.
(TIF)
S2 Fig. V. cholerae colonization of mice small intestine and colon measured by bacterial
recovery. WT and Cmah-/- mice were treated with 5mg/mL of streptomycin for 24 h prior to
oral infection and with 0.25mg/mL of streptomycin during the remaining experiment time,
both in the drinking water. The animals were infected with 2x108 CFU’s of V. cholerae and
small intestine fractions divided into jejunum (a), ileum (b) duodenum (c), and the colon (d)
were homogenized for Cholera CFU counts after serial dilutions were plated on (TCBS) agar
media. CFU recovery was determined in tissue fragments harvested from days 1, 2 and 3 after
infection.
(TIF)
S3 Fig. V. cholerae growth is modestly affected by sialic acid differences. Bacterial growth in
minimal M9 medium supplemented with 0.2% of glucose and concentrations of 3mM (a) 1.5
mM (b) 0.75mM (c) and 0.0375mM (d) of Neu5Ac or Neu5Gc was measured at each 30 min
interval during 24h using Bioscreen C system. Data is representative of three independent
experiments, with each condition done in quadruplicate.
(TIF)
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